Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial Cancer
Mayo Clinic
Mayo Clinic
National Cancer Institute, Naples
Regor Pharmaceuticals Inc.
Hospital Universitari de Bellvitge
University of Rochester
Radboud University Medical Center
Centre hospitalier de l'Université de Montréal (CHUM)
Cogent Biosciences, Inc.
Rutgers, The State University of New Jersey
GlaxoSmithKline
Qilu Pharmaceutical Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Kaiser Permanente
Ellele Health
Mayo Clinic
University Hospital, Strasbourg, France
University of Southern California
Asan Medical Center
European Institute of Oncology
UNC Lineberger Comprehensive Cancer Center
Women's Hospital School Of Medicine Zhejiang University
University Hospital Hradec Kralove
Taipei Veterans General Hospital, Taiwan
European Institute of Oncology
Natera, Inc.
Medical College of Wisconsin